OGI
Price
$1.89
Change
-$0.07 (-3.57%)
Updated
Oct 16 closing price
Capitalization
253.81M
Intraday Buy/Sell Signals
Interact to see
Advertisement

OGI

Header iconOGI Comparison
Open Charts OGIBanner chart's image
Organigram Global
Price$1.89
Change-$0.07 (-3.57%)
Volume$619.17K
Capitalization253.81M
OGI Comparison Chart in %
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), BioCryst Pharmaceuticals (NASDAQ:BCRX), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 3.93B. The market cap for tickers in the group ranges from 2.12K to 63.66B. AGN holds the highest valuation in this group at 63.66B. The lowest valued company is CANQF at 2.12K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was -1%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 52%. OVATF experienced the highest price growth at 117%, while MAJI experienced the biggest fall at -40%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was -39%. For the same stocks of the Industry, the average monthly volume growth was 35% and the average quarterly volume growth was 27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 65
Price Growth Rating: 54
SMR Rating: 100
Profit Risk Rating: 90
Seasonality Score: -1 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (OGI: $1.89)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGI’s FA Score shows that 1 FA rating(s) are green while.

  • OGI’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGI’s TA Score shows that 3 TA indicator(s) are bullish.

  • OGI’s TA Score: 3 bullish, 5 bearish.

Price Growth

OGI (@Pharmaceuticals: Generic) experienced а -6.44% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.44%. For the same industry, the average monthly price growth was +5.02%, and the average quarterly price growth was +52.32%.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.44% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OGI
Capitalization254M
EBITDA-959K
Gain YTD17.391
P/E Ratio221.23
Revenue224M
Total Cash36.8M
Total Debt9.15M
FUNDAMENTALS RATINGS
OGI: Fundamental Ratings
OGI
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
13

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OGI
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 15 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROHCY15.350.23
+1.52%
Rohm Co. Ltd.
BRKCF0.06N/A
N/A
Barksdale Resources Corp.
KUASF10.10N/A
N/A
KUAISHOU TECHNOLOGY
ANSNF0.07N/A
N/A
Anson Resources
CDDRF4.97-0.14
-2.81%
HEADWATER EXPL INC.

OGI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OGI has been closely correlated with SNDL. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if OGI jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGI
1D Price
Change %
OGI100%
-3.57%
SNDL - OGI
67%
Closely correlated
-4.03%
ACB - OGI
65%
Loosely correlated
-6.22%
TLRY - OGI
64%
Loosely correlated
-8.33%
CGC - OGI
62%
Loosely correlated
-7.53%
CRON - OGI
61%
Loosely correlated
-3.88%
More